X(ray) marks the spot in elemental analysis of 15th century printing press methods
Two UW–Madison researchers are part of a large, interdisciplinary team that is analyzing historical texts, including pages from a Gutenberg bible and Confucian texts, with a technique that could offer insights into early printing methods.
From student meetings to cream puffs, Cream City charms Chancellor Mnookin
After days of meetings around campus and in Dane County, Chancellor Jennifer Mnookin took her sixth day as the university’s 30th leader to emphasize the University of Wisconsin–Madison’s partnerships and build relationships in the Cream City.
See-through zebrafish, new imaging method put blood stem cells in high-resolution spotlight
This new technique will aid researchers as they develop therapies for blood diseases and cancers.
Recent Sightings
At summer youth camps, fun and learning go hand in hand UW–Madison offers a diverse range of summertime activities for young learners from ages 5-18 designed to exercise both the mind and the body. They… See more
Photo by Taylor Wolfram
Featured Expert
Paul Wilson: Nuclear plant at risk in Ukraine
Paul Wilson is a nuclear engineer and chair of the Engineering Physics department. A Russian-occupied nuclear power plant in Ukraine… More
Events calendar
August
- 14
-
14
1:00 pm, Meet at Grady Tract parking lot (SE corner Seminole Hwy & W Beltline Frontage Rd), UW–Madison Arboretum
- 14
- 15
- 16
Day 2: Chancellor Mnookin connects campus and community
Chancellor Jennifer L. Mnookin turned her focus toward UW–Madison’s partnerships with the Madison and Dane County community, and continued to listen and learn.
Chancellor Mnookin’s first day message to campus
Chancellor Mnookin shared email and video greetings with campus on her first day. She says her focus will be on listening and learning in order to understand UW's opportunities and challenges.
New injectable gel offers promise for tough-to-treat brain tumors
UW–Madison researchers have developed a powerful immunity-boosting postoperative treatment that could transform the odds for patients with glioblastoma.